Karas Eric
Insider CIK 1951287 · SPRY Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2026-06-12 | 2026-06-12 | 25,000 | — | $0 | 519,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2026-06-12 | 2026-06-12 | 25,000 | $10.00 | $250.0K | 12,176 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2026-06-12 | 2026-06-12 | 25,000 | $1.50 | $37.5K | 37,176 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 544,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-07-01 | 2025-07-03 | 15,000 | $16.99 | $254.8K | 10,315 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-07-01 | 2025-07-03 | 15,000 | $1.50 | $22.5K | 25,315 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-06-18 | 2025-06-20 | 15,000 | — | $0 | 559,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-06-18 | 2025-06-20 | 15,000 | $1.50 | $22.5K | 22,696 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 15,000 | $16.00 | $240.0K | 7,696 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2025-03-20 | 2025-03-21 | 10,000 | — | $0 | 574,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2025-03-20 | 2025-03-21 | 10,000 | $14.00 | $140.0K | 7,696 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2025-03-20 | 2025-03-21 | 10,000 | $1.50 | $15.0K | 17,696 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 152,300 | — | $0 | 152,300 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-04 | 2024-12-04 | 6,283 | — | $0 | 584,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-04 | 2024-12-04 | 6,283 | $1.50 | $9.4K | 11,976 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-04 | 2024-12-04 | 6,283 | $14.00 | $88.0K | 5,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-12-02 | 2024-12-04 | 3,717 | — | $0 | 590,871 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-12-02 | 2024-12-04 | 3,717 | $1.50 | $5.6K | 9,410 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 3,717 | $14.11 | $52.4K | 5,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-09-18 | 2024-09-19 | 10,000 | — | $0 | 594,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-09-18 | 2024-09-19 | 10,000 | $1.50 | $15.0K | 15,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-09-18 | 2024-09-19 | 10,000 | $14.00 | $140.0K | 5,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise deriv | 2024-08-19 | 2024-08-21 | 10,000 | — | $0 | 604,588 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-19 | 2024-08-21 | 10,000 | $14.00 | $140.0K | 5,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | M Exercise | 2024-08-19 | 2024-08-21 | 10,000 | $1.50 | $15.0K | 15,693 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2022-11-08 | 2022-11-10 | 614,588 | — | $0 | 614,588 | SEC↗ |